Does FERRIC CARBOXYMALTOSE Cause Injection site extravasation? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Injection site extravasation have been filed in association with FERRIC CARBOXYMALTOSE (Injectafer). This represents 0.4% of all adverse event reports for FERRIC CARBOXYMALTOSE.
30
Reports of Injection site extravasation with FERRIC CARBOXYMALTOSE
0.4%
of all FERRIC CARBOXYMALTOSE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site extravasation From FERRIC CARBOXYMALTOSE?
Of the 30 reports.
Is Injection site extravasation Listed in the Official Label?
Yes, Injection site extravasation is listed as a known adverse reaction in the official FDA drug label for FERRIC CARBOXYMALTOSE.
What Other Side Effects Does FERRIC CARBOXYMALTOSE Cause?
Hypophosphataemia (1,046)
Nausea (874)
Dyspnoea (737)
Headache (594)
Dizziness (528)
Pain (511)
Urticaria (509)
Pruritus (486)
Maternal exposure during pregnancy (468)
Vomiting (396)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which FERRIC CARBOXYMALTOSE Alternatives Have Lower Injection site extravasation Risk?
FERRIC CARBOXYMALTOSE vs FERRIC DERISOMALTOSE
FERRIC CARBOXYMALTOSE vs FERRIC HYDROXIDE
FERRIC CARBOXYMALTOSE vs FERRIC MALTOL
FERRIC CARBOXYMALTOSE vs FERRIC OXYHYDROXIDE
FERRIC CARBOXYMALTOSE vs FERROUS